Positive
●
Reuters
●
2 months ago
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator's nod, bolstering the drugmaker's efforts to diversify beyond its blockbuster cancer treatment Keytruda.